UROGENITAL CANCER
Clinical trials for UROGENITAL CANCER explained in plain language.
Never miss a new study
Get alerted when new UROGENITAL CANCER trials appear
Sign up with your email to follow new studies for UROGENITAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo aims to boost immune system against hard-to-treat urinary cancers
Disease control OngoingThis early-phase study tests two drugs, bintrafusp alfa and PDS01ADC, alone or with targeted radiation, in 100 adults with metastatic bladder, kidney, or other non-prostate genitourinary cancers. The goal is to see if the combination can help the immune system fight cancer better…
Matched conditions: UROGENITAL CANCER
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
Supercharged immune cells take on advanced cancers
Disease control OngoingThis early-phase trial tests a new approach to treat advanced solid tumors by giving patients a large dose of their own immune cells that are specially selected to attack cancer. The cells are taken from the tumor, multiplied in the lab, and then infused back. Some patients also …
Matched conditions: UROGENITAL CANCER
Phase: PHASE1 • Sponsor: AgonOx, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC